These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37596371)

  • 1. Identification an innovative classification and nomogram for predicting the prognosis of thyroid carcinoma patients and providing therapeutic schedules.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14817-14831. PubMed ID: 37596371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma.
    Song S; Zhou J; Zhang L; Sun Y; Zhang Q; Tan Y; Zhou X; Yu J
    Aging (Albany NY); 2024 Jun; 16(11):9753-9783. PubMed ID: 38836761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma.
    Du M; Qu Y; Qin L; Zheng J; Sun W
    J Cell Mol Med; 2024 Apr; 28(7):e18168. PubMed ID: 38494848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
    Wang L; Yao B; Yang J; Tian Z; He J
    BMC Cancer; 2022 Nov; 22(1):1131. PubMed ID: 36333684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
    Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PANoptosis-related genes as prognostic indicators of thyroid cancer.
    Xie D; Huang L; Li C; Wu R; Zheng Z; Liu F; Cheng H
    Heliyon; 2024 Jun; 10(11):e31707. PubMed ID: 38845990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of machine learning for developing a prognostic signature related to programmed cell death in colorectal cancer.
    Xu QT; Qiang JK; Huang ZY; Jiang WJ; Cui XM; Hu RH; Wang T; Yi XL; Li JY; Yu Z; Zhang S; Du T; Liu J; Jiang XH
    Environ Toxicol; 2024 May; 39(5):2908-2926. PubMed ID: 38299230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis and therapy in thyroid cancer by gene signatures related to natural killer cells.
    Jin Z; Han Y; Zhang J; Liu Z; Li R; Liu Z
    J Gene Med; 2024 Jan; 26(1):e3657. PubMed ID: 38282150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery.
    Zou Y; Xie J; Zheng S; Liu W; Tang Y; Tian W; Deng X; Wu L; Zhang Y; Wong CW; Tan D; Liu Q; Xie X
    Int J Surg; 2022 Nov; 107():106936. PubMed ID: 36341760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
    Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
    Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Potential Four-Gene Signature and Nomogram for Predicting the Overall Survival of Papillary Thyroid Cancer.
    Ding Y; Li P; Wang W; Liu F
    Dis Markers; 2022; 2022():8735551. PubMed ID: 36193505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic signature related to programmed cell death in osteosarcoma.
    Jiang YC; Xu QT; Wang HB; Ren SY; Zhang Y
    Front Immunol; 2024; 15():1427661. PubMed ID: 39015570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction and validation of a PANoptosis-related lncRNA signature for predicting prognosis and targeted drug response in thyroid cancer.
    Li R; Zhao M; Sun M; Miao C; Lu J
    PeerJ; 2023; 11():e15884. PubMed ID: 37671354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Potential Molecular Subtypes and Signatures of Thyroid Carcinoma Based on Aging-related Gene Analysis.
    Li Z; Jia LI; Zhou HR; Zhang LU; Zhang M; Lv J; Deng ZY; Liu C
    Cancer Genomics Proteomics; 2024; 21(1):102-117. PubMed ID: 38151291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.